AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor
The purpose of this study is to determine the recommended dose of the combination of AVE8062 with platinum salts (cisplatin or carboplatin) and taxanes (docetaxel or paclitaxel) in patients with advanced solid tumors for which platinum-taxane doublet constitutes mainstay of care.
Neoplasms
DRUG: OMBRABULIN (AVE8062)
Recommended dose of the combination based on Dose Limiting Toxicities observed, Cycle 1
Overall safety profile, Treatment period|Pharmacokinetic profile, Cycle 1|Anti-tumor activity of the combination, Every 2 cycles
The purpose of this study is to determine the recommended dose of the combination of AVE8062 with platinum salts (cisplatin or carboplatin) and taxanes (docetaxel or paclitaxel) in patients with advanced solid tumors for which platinum-taxane doublet constitutes mainstay of care.